Histone variant H2A.J is an epigenetic regulator of metastasis in lung adenocarcinoma

Dong-Gun Kim, Eun-Young Choi, Hye-Mi Ahn, Kyungho Kim, Youn-Jae Kim

Open source

DOI
10.1038/s41419-026-09054-9
Published
2026-06-26
Container
Cell Death & Disease
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41419-026-09054-9,
  title = {Histone variant H2A.J is an epigenetic regulator of metastasis in lung adenocarcinoma},
  author = {Dong-Gun Kim and Eun-Young Choi and Hye-Mi Ahn and Kyungho Kim and Youn-Jae Kim},
  year = {2026},
  journal = {Cell Death \& Disease},
  doi = {10.1038/s41419-026-09054-9},
  url = {https://doi.org/10.1038/s41419-026-09054-9}
}

RIS

TY  - JOUR
TI  - Histone variant H2A.J is an epigenetic regulator of metastasis in lung adenocarcinoma
AU  - Dong-Gun Kim
AU  - Eun-Young Choi
AU  - Hye-Mi Ahn
AU  - Kyungho Kim
AU  - Youn-Jae Kim
PY  - 2026
JO  - Cell Death & Disease
DO  - 10.1038/s41419-026-09054-9
UR  - https://doi.org/10.1038/s41419-026-09054-9
ER  - 

APA

Kim, D., Choi, E., Ahn, H., Kim, K., & Kim, Y. (2026). Histone variant H2A.J is an epigenetic regulator of metastasis in lung adenocarcinoma. Cell Death & Disease. https://doi.org/10.1038/s41419-026-09054-9

Source records